Vastarel MR 35 mg

Indication

Add-on therapy for the symptomatic treatment of adults with stable angina pectoris who are inadequately controlled by, or intolerant to, first-line antianginal therapies.

Ingredients

• Trimetazidine dihydrochloride 35 mg

Direction

One 35 mg tablet twice daily, morning and evening, during meals. Swallow whole with water; do not crush or chew. Dose may be reduced in moderate kidney impairment and in the elderly as directed by the doctor.

Side effects

• Dizziness
• headache
• Abdominal pain
• diarrhoea
• indigestion
• nausea
• vomiting
• Rash
• itching
• weakness
• Rarely
• movement disorders (tremor
• stiffness
• unsteady walking
• parkinsonian symptoms)
• usually reversible after stopping
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.

Precautions

• Prescription medicine
• not a treatment for an acute angina attack
• Do not use in Parkinson's disease
• tremor
• restless legs syndrome or other movement disorders
• or in severe kidney impairment
• May cause dizziness
• take care when driving or operating machinery
• Not recommended during pregnancy or breastfeeding
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.